Six Corporate Oversights of Quality and Compliance Issues in Pharmaceutical Environments

This white paper presents six significant quality and compliance oversights that pharmaceutical companies may unknowingly propagate or encourage over time. At a corporate level, quality and compliance management in heavily regulated pharmaceutical environments is a tricky endeavor. After all, success in the areas of quality and compliance can only be achieved when a multitude of variables are controlled and continually maintained. This white paper will discuss how to improve upon: